Latest Breaking News On - Shankar musunuri - Page 6 : comparemela.com

Ocugen, Inc Announces Bob Smith Joins Business Advisory Board

MALVERN, Pa., Jan. 16, 2024 Ocugen, Inc. , a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies, biologics, and vaccines, today.

Bob smithDennis careyJosephw westphalConnie collingsworthShankar musunuriPat toomeyOcugen incCompany business advisory boardLeadership teamExchange commissionHead of corporate communicationsSenior vice presidentGlobal gene therapy businessBusiness advisory boardSenator pat toomeyAmbassador joseph

Ocugen (OCGN) Appoints Bob Smith to its Advisory Board

Ocugen (OCGN) Appoints Bob Smith to its Advisory Board
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Dennis careyConnie collingsworthBob smithShankar musunuriJosephw westphalPat toomeyLeadership teamOcugen incCompany business advisory boardSenior vice presidentGlobal gene therapy businessBusiness advisory boardSenator pat toomeyAmbassador josephExecutive leadership team

Ocugen, Inc Announces Bob Smith Joins Business Advisory Board - Ocugen (NASDAQ:OCGN)

MALVERN, Pa., Jan. 16, 2024 (GLOBE NEWSWIRE) Ocugen, Inc. (Ocugen or the Company) (NASDAQ:OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies,

Connie collingsworthDennis careyShankar musunuriPat toomeyJosephw westphalBob smithLeadership teamExchange commissionOcugen incCompany business advisory boardSenior vice presidentGlobal gene therapy businessBusiness advisory boardSenator pat toomeyAmbassador josephExecutive leadership team

Ocugen, Inc Announces Bob Smith Joins Business Advisory

MALVERN, Pa., Jan. 16, 2024 (GLOBE NEWSWIRE) Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering,.

Dennis careyBob smithPat toomeyShankar musunuriJosephw westphalConnie collingsworthExchange commissionOcugen incCompany business advisory boardLeadership teamSenior vice presidentGlobal gene therapy businessBusiness advisory boardSenator pat toomeyAmbassador josephExecutive leadership team

Ocugen (OCGN) Gains FDA Alignment on Key Aspects of OCU400—Modifier Gene Therapy—Phase 3 Study Design

Ocugen (OCGN) Gains FDA Alignment on Key Aspects of OCU400—Modifier Gene Therapy—Phase 3 Study Design
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesShankar musunuriOcugen incRetinitis pigmentosaChief executive officer